Ireland-U.S. Council honour Randox founder with Business Relations Award
The Ireland-U.S. Council in America have this week presented the founder of healthcare diagnostics company Randox Laboratories with an award marking significant achievement in building relations between Northern Ireland and the United States of America.
Presented to Dr Peter FitzGerald at the 56th Annual Dinner of the Ireland-U.S. Council yesterday evening, the accolade, named the Cúchulainn award, recognizes the efforts of individuals who go above and beyond to support the objectives of the Ireland-U.S. Council – to improve the business bonds and commercial connections between Ireland, Northern Ireland and the United States.
Joining an exclusive line-up of some of the most prominent business figures in both Ireland and the United States recognized by the Ireland-U.S. Council, including CEO of International Airlines Group William Walsh, Dr FitzGerald was presented with the prestigious award at The Metropolitan Club in New York City.
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“I am most honoured to be here this evening to accept the Cúchulainn award from the Ireland-U.S. Council in recognition of the work undertaken by Randox in the United States since the early 1980s when we began to export our diagnostic healthcare products. The United States remains one of Randox’s most important markets, in which we are growing at pace thanks to the ongoing development of innovative new products in not only the healthcare sector, but also the veterinary, research, toxicology and food safety industries.”
The Ireland-U.S. Council was founded in 1962 by a group of American and Irish business leaders as a measure to build an established structure which would encourage closer economic relations, and was initially created to assist in making preparations for the first-ever State Visit of a sitting U.S. President to Ireland by President John F. Kennedy from June 26 – 29 in 1963.
David O’Sullivan, Executive Director of the Ireland–U.S. Council, added;
“Ever since the State Visit to Ireland by President John F. Kennedy, the Ireland-U.S. Council has been engaged in efforts to achieve our transatlantic mission. Dr FitzGerald of Randox Laboratories truly embodies the essence of this mission by aligning his business in Ireland closely with businesses in the US, to maximise the positive outcomes for both parties. We are delighted to present him this evening with the Cúchulainn award – for the significant contributions he has made to the development of closer economic, business and commercial ties between our two nations.”
For further information please email email@example.com
A Scottish trade delegation, led by the country’s Minister for Trade, Investment and Innovation Ivan McKee, visited several companies in the Gaeltacht area of Donegal this week, including Randox Teoranta in Dungloe, Donegal.
Randox Laboratories Ltd was established in County Antrim in 1982 to address the need for accurate and readily available diagnostic tests to improve patient diagnoses, and Randox Teoranta in Donegal was subsequently opened in 2008.
A dedicated R&D and manufacturing biohub, Randox Teoranta researches, develops and manufactures a range of unique tests on the Randox Biochip.
Exporting over 95% of its products worldwide, Randox has a global vision and staff at Randox Teoranta have the opportunity to interact with like-minded innovators across the world, including the University of Nottingham, the Royal Derby Hospital, Pacific Biomarkers in Seattle, USA, The British Psychological Society and the Medical University of Vienna, to name but a few.
On Friday 19th October the trade delegation to visit Randox Teoranta, hosted by Údarás na Gaeltachta, announced a new trade partnership agreement between Scotland and the Donegal Gaeltacht.
The trade mission was set up to prove that challenges for businesses in Scotland and Donegal can be overcome by working together.
For Scottish companies setting up in somewhere in the Gaeltacht and for companies from the Gaeltacht interested in establishing themselves in Scotland, they can access the market to test its feasibility, with the support of Údaras na Gaeltachta and Scottish Chambers of Commerce.
For more information on the Scottish Trade Delegation to Randox Teoranta please contact the Randox PR team on 028 9442 2413 or by emailing firstname.lastname@example.org
With the demand for cocaine in the UK rocketing, Top British Chef Gordon Ramsay has recently travelled to Columbia to the source of the problem, to learn more about this growing epidemic.
Having spent time with local farmers who own cocaine plants that resemble vineyards, and visiting Honduras, one of the most dangerous countries and known as the world’s warehouse of cocaine, he emphasized the urgent need to combat the drugs industry that is consuming this country.
Highlighted throughout the two-part series was the amount of cocaine that is being trafficked to the shores of the UK each year. Speaking with the metropolitan police who tackle up to 200 drug gangs in London alone, it was estimated that up to 300 tons of cocaine, with a street value of £10 billion, is being brought in to the country through a web of secretive routes used by drug traffickers.
Gordon commented that not only is cocaine a growing global problem, but it is one that is prevalent within the culinary world, including his own restaurants where he has been asked to dust the drug on top of soufflés as icing sugar, and found traces of this deadly drug in both his staff and customer toilets.
With the cocaine problem showing no signs of slowing down, Randox Toxicology are constantly working to develop the newest drug tests to meet the demands of the ever-growing drug market. The Evidence MultiSTAT was developed for use in non-laboratory settings such as workplaces, police stations and low throughput laboratories and to provide highly accurate qualitative as quickly as possible.
This revolutionary analyser enables on-site simultaneous detection of up to 21 classical, prescription and synthetic drugs from a single patient sample, reducing the burden on current systems, the risk of adulteration and helping the fight against the cartels who control the cocaine trade in South America.
For more information on our Evidence Analysers or any of our drug panels email email@example.com